EcoDrugPlus

Ensembl ID : ML270515a
Gene Symbol: -
External references: -
50 Possible Orthologues:

Ensembl ID : ML273213a
Gene Symbol: -
External references: -
159 Possible Orthologues:

Ensembl ID : ML273222a
Gene Symbol: -
External references: -
262 Possible Orthologues:

Ensembl ID : ML27361a
Gene Symbol: -
External references: -
239 Possible Orthologues:

Ensembl ID : ML27362a
Gene Symbol: -
External references: -
239 Possible Orthologues:

Ensembl ID : ML274432a
Gene Symbol: -
External references: -
516 Possible Orthologues:

Ensembl ID : ML274433a
Gene Symbol: -
External references: -
516 Possible Orthologues:

Ensembl ID : ML27841a
Gene Symbol: -
External references: -
260 Possible Orthologues:

Ensembl ID : ML279512a
Gene Symbol: -
External references: -
246 Possible Orthologues:

Ensembl ID : ML279516a
Gene Symbol: -
External references: -
129 Possible Orthologues:

Ensembl ID : ML282510a
Gene Symbol: -
External references: -
191 Possible Orthologues:

Ensembl ID : ML282512a
Gene Symbol: -
External references: -
74 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).